ALK presented positive phase II data from its ALLIANCE trial on a once-daily sublingual immunotherapy tablet for peanut allergy at the ACAAI 2026 meeting. The trial with 150 patients showed the tablet was effective across all ages after six months, well-tolerated, and had no serious adverse events. These promising results support moving forward to phase III trials, aiming to offer a new treatment option for peanut allergy, a serious condition affecting millions with limited current therapies.
ALK's positive phase II data on its peanut allergy tablet is presented here with Pluang's Health sector market snapshot as of Nov 12, 2026 20:12 WIB: of 150 priced Health-sector US stocks tradable on Pluang, 82 rose and 64 fell today. Notable movers include HIMS at USD 19.77 with a 1-day change of -5.00% and Pluang order activity showing 82% Sell / 18% Buy, BNGO at USD 1.15 up 4.55% with 44% Sell / 56% Buy, and TXG at USD 59.30 down 4.43% with 48% Sell / 52% Buy. The highest Pluang order sell activity is 82% for HIMS.
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
atQor has been named a finalist for the 2026 Microsoft Partner of the Year Award in the Agents category, recognized for its innovative and scalable agentic AI solutions deployed across nine industries. The company developed 252 AI agents in FY26, wit...
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
